Matter: What’s Behind Many Mystery Ailments? Genetic Mutations, Study Finds
The study, published Thursday in Science, represents the first large-scale search of electronic health records for hidden Mendelian diseases. But Dr. Joshua C. Denny, a biomedical informatics researcher at the Vanderbilt University School of Medicine and co-author of the new study, suspected that it only revealed the tip of a genetic iceberg. Much larger databases including DNA and records for hundreds of thousands of people are being built, and searching them may uncover many more hidden mutations.
“I’m sure there’s a whole bunch else out there that we will discover,” Dr. Denny said.
He and his colleagues gathered data from Vanderbilt’s massive electronic health records system, which includes more than two million patients. More than 225,000 have signed up as volunteers for genetic research, allowing scientists to analyze their DNA.
The researchers picked out 21,701 patients from the database and surveyed all the symptoms recorded for each one. They then compared the symptoms to those seen in 1,204 Mendelian diseases.
It was a difficult task. These disorders can produce a number of symptoms, and each patient may have a different combination of them.
And some symptoms linked to a Mendelian disease may also be signs of other diseases. Cystic fibrosis can cause asthma and recurrent infections, for instance — but those symptoms alone aren’t enough to diagnose the disease.
Dr. Denny and his colleagues developed a scoring system to determine how likely it was that each patient in their study suffered each Mendelian disease. If a patient had a rare symptom linked to a disease, she scored a lot of points. A common symptom earned her far fewer points.
The researchers identified groups of people with symptoms strongly suggesting they shared a Mendelian disease. The researchers went on to examine the DNA of these patients to see if they also shared a mutation.
Dr. Denny would have been happy just to find a few undiagnosed patients. Instead, the team found 807 patients carrying mutations in genes linked to 17 different diseases, such as cystic fibrosis or hemochromatosis, a disorder that causes iron to build up in the blood.
Only eight of these patients had gotten a test that revealed the mutation. In other cases, doctors had tested for the wrong disease and gotten a negative result. Many times, the doctors hadn’t ordered any genetic tests at all.
Typically, these disorders can be passed down in one of two ways. A dominant disease, like Huntington’s, requires inheriting just one defective copy of a gene from a parent. Recessive diseases, such as sickle cell anemia, usually require two defective copies of the same gene.
The mutations that the scientists discovered often didn’t fit the standard profile for the diseases. Many of the patients had conditions that are considered recessive, yet they carried a just single defective copy of the gene.
A single defective copy may cause milder versions of Mendelian diseases, Dr. Denny suspects.
The researchers identified 36 people, for example, who carried only one defective version of a gene called AGXT. Two copies of the gene cause a disease known as primary hyperoxaluria, which can result in kidney failure in toddlers. The patients identified in the new study also suffered kidney problems — but not in the first few years of life.
One patient who turned up in their search had kidney stones at age 15. That’s unusual — but apparently not enough to lead the patient’s doctors to suspect primary hyperoxaluria.
“It’s not as simple as what we learned in high school genetics,” Dr. Denny said.
These results are all the more surprising given how modest Dr. Denny’s search was. He only looked for a limited number of mutations in a relatively small group of people, all of whom were of European descent. (Much of what is known about gene variants that cause disease was discovered by researching predominantly white populations.)
“I’m kind of surprised we found anything. The fact that we did means there’s maybe a lot out there that we don’t know,” Dr. Denny said.
Heidi L. Rehm, a molecular geneticist at Brigham and Women’s Hospital who was not involved in the study, said many doctors do not suspect that their patients are suffering from a Mendelian disorder unless they suffer severe textbook symptoms.
“They simply never order any genetic testing, and then you never develop an understanding that it’s genetic to begin with,” she said.
Overlooking the genetic causes of diseases can seriously harm patients. “There are people here who had kidney and liver transplants that could potentially have been avoided,” Dr. Denny said.
Undiagnosed hemochromatosis, for example, can lead to liver failure. Of the 40 people Dr. Denny and his colleagues identified with hemochromatosis, four needed liver transplants.
Yet hemochromatosis can be readily treated by having patients donate blood on a regular basis, which helps rid them of excess iron.
The strategy employed by the research team was startlingly effective at identifying potential causes of disease. In the long run, Dr. Denny and Dr. Rehm agreed, the best solution might be to sequence the entire genome of every patient — in childhood, or even at birth.
But such a policy would create an unmanageable glut of genetic data.
“I don’t think we’re ready to do that,” Dr. Denny said.